Lionco Pharm Grp Co Ltd (603669) — Cash Flow Quality Index

Latest as of September 2025: -64.27x

Lionco Pharm Grp Co Ltd (603669) has a Cash Flow Quality Index of -64.27x as of September 2025. Operating cash flow of CN¥-79.09 Million is below net income of CN¥1.23 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Lionco Pharm Grp Co Ltd (603669) investment intensity to see how much of total assets are deployed in long-term investments.

Cash Flow Quality Index

-64.27x
Operating CF / Net Income

Operating Cash Flow

CN¥-79.09 Million
CNY

Net Income

CN¥1.23 Million
CNY

Data as of

Sep 2025
Most recent filing

Lionco Pharm Grp Co Ltd Cash Flow Quality Index (2012–2021)

Historical Cash Flow Quality Index for Lionco Pharm Grp Co Ltd across 10 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Lionco Pharm Grp Co Ltd tangible book value ratio to evaluate the tangible quality of the company's equity base.

Annual Cash Flow Quality Index for Lionco Pharm Grp Co Ltd (2012–2021)

Year-by-year earnings quality comparison for Lionco Pharm Grp Co Ltd. For live market cap and the full company financial profile, see 603669 stock market capitalisation.

Year Quality Index Operating CF (CNY) Net Income YoY Change
2021 1.95x CN¥128.50 Million CN¥65.90 Million ▲ +146.1%
2020 0.79x CN¥126.81 Million CN¥160.07 Million ▼ -32.2%
2019 1.17x CN¥235.61 Million CN¥201.59 Million ▲ +14.9%
2018 1.02x CN¥185.87 Million CN¥182.70 Million ▼ -13.3%
2017 1.17x CN¥189.01 Million CN¥161.01 Million ▼ -0.9%
2016 1.18x CN¥182.27 Million CN¥153.93 Million ▲ +79.3%
2015 0.66x CN¥98.88 Million CN¥149.69 Million ▼ -45.5%
2014 1.21x CN¥181.50 Million CN¥149.86 Million ▼ -13.5%
2013 1.40x CN¥160.77 Million CN¥114.80 Million ▼ -6.5%
2012 1.50x CN¥142.61 Million CN¥95.17 Million
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.